Metabolite profiling can change health-care delivery to obese patients with fatty liver disease: The search for biomarkers

Clinical Chemistry and Laboratory Medicine

Volumn 55, Issue 4, 2017, Pages 501-506

  Camps, Jordi ^a   Joven, Jorge ^a  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

Author keywords

biomarkers; metabolomics; mitochondria; obesity; steatosis

Indexed keywords

2 OXOISOVALERIC ACID; 3 HYDROXYBUTYRIC ACID; ACETALDEHYDE; ACETONE; ACID; BIOLOGICAL MARKER; BRANCHED CHAIN AMINO ACID; CARBOXYLIC ACID; CHAPERONE; CHEMOKINE; FATTY ACID; FOLIC ACID; G PROTEIN COUPLED RECEPTOR; ISOLEUCINE; ISOPRENE; LACTIC ACID; LIPID; PENTANE; PHOSPHOLIPID; REACTIVE OXYGEN METABOLITE; TRIMETHYLAMINE; VALINE; CARBON NANOTUBE; DICARBOXYLIC ACID; OXOACID; VOLATILE AGENT; 2 OXOGLUTARIC ACID; ALPHA-KETOGLUTARIC ACID; CARBON;

ADIPOCYTE; ARTICLE; CITRIC ACID CYCLE; ENDOPLASMIC RETICULUM STRESS; ENERGY METABOLISM; FATTY ACID OXIDATION; FATTY LIVER; GLUCOSE METABOLISM; HEALTH CARE DELIVERY; HOMEOSTASIS; HUMAN; METABOLITE; METABOLOMICS; MITOCHONDRIAL BIOGENESIS; MOLECULAR DIAGNOSIS; OBESITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW (TOPIC); UNFOLDED PROTEIN RESPONSE; BIOSENSOR; CHRONIC INFLAMMATION; ELECTRODE; EXPIRED AIR; FOOD INTAKE; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METABOLIC DISORDER; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; BLOOD; COMPLICATION; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PROCEDURES;

BIOMARKERS; CARBON; HUMANS; KETOGLUTARIC ACIDS; METABOLOMICS; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY;

EID: 85016027814     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2016-0762     Document Type: Article

References (31)

1. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity among adults: United States, 2011-2012. NCHS Data Brief 2013;131:1-8.
2. Joven J, Micol V, Segura-Carretero A, Alonso-Villaverde C, Menendez JA. Polyphenols and the modulation of gene expression pathways: can we eat our way out of the danger of chronic disease? Crit Rev Food Sci Nutr 2013;54:985-1001.
3. Hagström H, Stal P, Hultcrantz R, Hemmingsson T, Andreasson A. Overweight in late adolescence predicts development of severe liver disease later in life: A 39years follow-up study. J Hepatol 2016;65:363-8.
4. Guy CD, Suzuki A, Burchette JL, Brunt EM, Abdelmalek MF, Cardona D, et al. Nonalcoholic steatohepatitis clinical research network. Co-staining for keratins 8/18 plus ubiquitin improves detection of hepatocyte injury in nonalcoholic fatty liver disease. Hum Pathol 2012;43:790-800.
5. Serviddio G, Bellanti F, Vendemiale G. Free radical biology for medicine: learning from nonalcoholic fatty liver disease. Free Radic Biol Med 2013;65:952-68.
6. Roessner U, Bowne J. What is metabolomics all about? Biotechniques 2009;46:363-5.
7. Rauschert S, Uhl O, Koletzko B, Hellmuth C. Metabolomic biomarkers for obesity in humans: a short review. Ann Nutr Metab 2014;64:314-24.
8. Mirza MS. Obesity, visceral fat and NAFLD: querying the role of adipokines in the progression of nonalcoholic fatty liver disease. ISRN Gastroenterol 2011;2011:592404.
9. Rogge MM. The role of impaired mitochondrial lipid oxidation in obesity. Biol Res Nurs 2009;10:356-73.
10. de Ferranti S, Mozaffarian D. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem 2008;54:945-55.
11. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007;8:519-29.
12. Camps J, García-Heredia A, Hernández-Aguilera A, Joven J. Paraoxonases, mitochondrial dysfunction and non-communicable diseases. Chem Biol Interact 2016; doi: 10.1016/j. cbi.2016.04.005. [Epub ahead of print].
13. Camps J, Rodríguez-Gallego E, García-Heredia A, Triguero I, Riera-Borrull M, Hernández-Aguilera A, et al. Paraoxonases and chemokine (C-C motif) ligand-2 in non-communicable diseases. Adv Clin Chem 2014;63:247-308.
14. Hernández-Aguilera A, Rull A, Rodríguez-Gallego E, Riera-Borrull M, Luciano-Mateo F, Camps J, et al. Mitochondrial dysfunction: a basic mechanism in inflammation-related non-communicable diseases and therapeutic opportunities. Mediators Inflamm 2013;2013:135698.
15. Hernández-Aguilera A, Fernández-Arroyo S, Luciano-Mateo F, Cabré N, Camps J, López-Miranda J, et al. Chronic nutrient toxicity causing metabolic variations and high risk of disease through changes in DNA-methylation. Food Chem Toxicol 2016;96:191-204.
16. Haas R, Smith J, Rocher-Ros V, Nadkarni S, Montero-Melendez T, D'Acquisto F, et al. Lactate regulates metabolic and proinflammatory circuits in control of T cell migration and effector functions. PLoS Biol 2015;13:e1002202.
17. Liu C, Wu J, Zhu J, Kuei C, Yu J, Shelton J, et al. Lactate inhibits lipolysis in fat cells through activation of an orphan G-proteincoupled receptor, GPR81. J Biol Chem 2009;284:2811-2.
18. Hashimoto T, Hussien R, Brooks GA. Co-localization of MCT1, CD147, and LDH in mitochondrial inner membrane of L6 muscle cells: evidence of a mitochondrial lactate oxidation complex. Am J Physiol Endocrinol Metab 2006;290:E1237-44.
19. Gonzalez NS, Communi D, Hannedouche S, Boeynaems JM. The fate of P2Y-related orphan receptors: GPR80/99 and GPR91 are receptors of dicarboxylic acids. Purinergic Signal 2004;1:17-20.
20. Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, et al. Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 2013;339:211-4.
21. Haas R, Cucchi D, Smith J, Pucino V, Macdougall CE, Mauro C. Intermediates of metabolism: from bystanders to signalling molecules. Trends Biochem Sci 2016; 41:460-71.
22. Alkhouri N, Cikach F, Eng K, Moses J, Patel N, Yan C, et al. Analysis of breath volatile organic compounds as non-invasive tool to diagnose non-alcoholic fatty liver disease in children. Eur J Gastroenterol Hepatol 2014;26:82-7.
23. Hanouneh IA, Zein NN, Cikach F, Dababneh D, Grove D, Alkhouri N, et al. The breathprints in patients with liver disease identify novel breath biomarkers of alcoholic hepatitis. Clin Gastroenterol Hepatol 2014;12:516-23.
24. Alkhouri N, Eng K, Cikach F, Patel N, Yan C, Brindle A, et al. Breathprints of childhood obesity: changes in volatile organic compounds in obese children compared with lean controls. Pediatr Obes 2015;10:23-9.
25. Smith D, Španěl P, Herbig J, Beauchamp J. Mass spectrometry for real-time quantitative breath analysis. J Breath Res 2014;8:027101.
26. Rodríguez-Gallego E, Guirro M, Riera-Borrull M, Hernández-Aguilera A, Mariné-Casadó R, Fernández-Arroyo S, et al. Mapping of the circulating metabolome reveals α-ketoglutarate as a predictor of morbid obesity-associated non-alcoholic fatty liver disease. Int J Obes (Lond) 2015;39:279-87.
27. Riera-Borrull M, Rodríguez-Gallego E, Hernández-Aguilera A, Luciano F, Ras R, Cuyas E, et al. Exploring the process of energy generation in pathophysiology by targeted metabolomics: performance of a simple and quantitative Method. J Am Soc Mass Spectrom 2016;27:168-77.
28. Bao XR, Ong SE, Goldberger O, Peng J, Sharma R, Thompson DA, et al. Mitochondrial dysfunction remodels one-carbon metabolism in human cells. Elife 2016;5:e10575.
29. Ron-Harel N, Santos D, Ghergurovich JM, Sage PT, Reddy A, Lovitch SB, et al. Mitochondrial biogenesis and proteome remodeling promote one-carbon metabolism for T cell activation. Cell Metab 2016;24:104-117.
30. Long JZ, Svensson KJ, Bateman LA, Lin H, Kamenecka T, Lokurkar IA, et al. The secreted enzyme PM20D1 regulates lipidated amino acid uncouplers of mitochondria. Cell 2016;166:424-35.
31. Guerrero S, Martínez-García G, Serafín V, Agüí L, Yánez-Sedeno P, Pingarrón JM. Electrochemical immunosensor for sensitive determination of the anorexigen peptide YY at grafted reduced graphene oxide electrode platforms. Analyst 2015;140:7527-33.